Brief: ImmuPharma Provides Lupuzor™ Update
27/03/2023 08:24
March 27 (Reuters) - ImmuPharma PLC IMM.L :
* IMMUPHARMA PLC - LUPUZOR™ UPDATE
* IMMUPHARMA PLC - AVION SUBMITS CLINICAL PROTOCOL OF PHASE
2/3
ADAPTIVE STUDY OF LUPUZOR™ IN LUPUS TO FDA
Source text for Eikon: ID:nRSa2290Ua
Further company coverage: IMM.L
((Reuters.Briefs@thomsonreuters.com;;))